Home > News > Zyvex Continues to Exceed Sales Expectations
January 26th, 2005
Zyvex Continues to Exceed Sales Expectations
Zyvex today announced financial results for its fiscal 2004 fourth quarter. The Texas company continues its business gains with nine consecutive quarters of sales growth and expansion of its global sales reach.
Total revenue for the fourth quarter was $4.0 million, which was a 55 percent increase over the same period in 2003.
The total revenue for 2004 was $8.6 million, which represented a 102 percent increase over 2003. International sales, new to the company during 2004, accounted for 10 percent of the year’s revenue.
Whirlpools on the Nanoscale Could Multiply Magnetic Memory: At the Advanced Light Source, Berkeley Lab scientists join an international team to control spin orientation in magnetic nanodisks May 22nd, 2013
Bacterial spare parts filter antibiotic residue from groundwater May 22nd, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Atomic-Scale Investigations Solve Key Puzzle of LED Efficiency: MIT and Brookhaven Lab scientists use electron microscopy imaging techniques to settle a solid-state controversy and raise new experimental possibilities May 22nd, 2013
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013
Arrowhead Reports Fiscal 2013 Second Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time May 9th, 2013
Arrowhead to Report Fiscal 2013 Second Quarter Financial Results - Conference Call Scheduled for Thursday, May 9, 2013 May 2nd, 2013